Use of substituted cyclopropane acid derivatives for producing drugs for use in the treatment of metabolic syndrome

Details for Australian Patent Application No. 2005315975 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Heuer, Hubert; Kadereit, Dieter; Brummerhop, Harm; Stengelin, Siegfried

Agent Watermark

Pub. Number AU-A-2005315975

PCT Pub. Number WO2006/063681

Priority 10 2005 039 245.8 19.08.05 DE; 10 2004 060 041.4 14.12.04 DE

Filing date 30 November 2005

Wipo publication date 22 June 2006

International Classifications

A61K 31/215 (2006.01)

A61P 3/06 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/063681 Priority application(s): WO2006/063681

3 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005315984-Process for making bouillon or seasoning cubes

2005315960-Process for the preparation of galanthamine hydrobromide